Seven NHS trusts in England are set to begin trials of new wireless technologies to help improve patient care and strengthen connectivity in A&Es and
ambulance bays.
They have been awarded around £1 million as part of NHS England's Wireless Trials programme, which aims to leverage advanced wireless technologies to enhance
patient care and experiences while freeing up more staff time.
Manchester University NHS Foundation Trust will introduce an innovative approach of combining satellite and cloud-based wireless solutions to enhance connectivity
across its 10 hospital sites and wider community services.
At Mid Cheshire and Princess Alexandra Hospital NHS trusts, wireless trackers will be installed on medical equipment and hospital beds. This will allow real-time
monitoring and location tracking, enabling easy accessibility for staff to locate necessary items promptly.
The General Pharmaceutical Council (GPhC) has announced the names of five new members who will be joining its governing Council over the next two years.
The new council members are:
Professor Dianne Ford, Pro Vice-Chancellor of the Faculty of Health and Life Sciences at Northumbria University.
Gareth Powell, a chartered accountant and a Non-Executive Director on the Board of the Port of Milford Haven, the UK's largest energy port.
Adeyemi (Ade) Williams MBE, Superintendent Pharmacist and Director of the M J Williams Pharmacy and lead Pharmacist at the Bedminster Pharmacy, Bristol.
Tim Jaggard, Deputy Chief Executive and Chief Financial Officer at University College London Hospitals NHS Foundation Trust.
Dr Raliat Onatade, Chief Pharmacist and Director of Medicines and Pharmacy for North-East London Integrated Care System.
Professor Ford, Powell and Williams will begin their terms on 1 April 2024, replacing Jo Kember, Mark Hammond and Arun Midha.
Achieving and maintaining healthy-looking skin is a journey that requires dedication and a well-rounded approach. Our skin, the largest organ in our body,
deserves the utmost care to thrive. In this comprehensive guide, we will delve into a step-by-step approach that encompasses various aspects of skincare,
from daily routines to advanced treatments. Discover the secrets to a radiant complexion that not only looks good but also reflects your overall well-being.
Establish a Consistent Daily Routine
A consistent daily skincare routine is the bedrock for achieving and maintaining healthy skin. This foundational step involves a series of carefully chosen
products and practices that work together to nourish, protect, and rejuvenate your skin. Begin your routine with a gentle cleanser to remove impurities and prepare
your skin for subsequent products. Follow this with a balancing toner to restore your skin's pH and create an optimal environment for absorption. Integrate a
quality moisturizer to keep your skin hydrated and maintain its natural barrier. Don't overlook the importance of sunscreen in the morning to shield your skin
from the harmful effects of UV rays. This daily ritual not only provides essential nutrients for your skin but also establishes a preventive measure against
environmental stressors, setting the stage for a radiant and healthy complexion.
A groundbreaking research project has revealed that the public is urging the government to prioritise primary and community care over hospitals.
The study also found a strong public willingness to pay higher taxes to enhance NHS services.
The Health Foundation and Ipsos UK conducted the research, combining nationwide polling with in-depth public deliberative workshops.
These workshops, held in King's Lynn, Leeds, and London, constitute one of the most comprehensive public consultations about the future of the NHS in England.
The study published on 16 May underscores the public's desire for a redistribution of NHS resources. If the NHS budget remains unchanged, 60 per cent of those
polled believe the government should focus on improving access to community-based services like general practice and dentistry.
When faced with the unfortunate situation of medical malpractice, it's understandable that you may feel overwhelmed and uncertain about the next steps. One
crucial aspect that often gets overlooked in the turmoil is the importance of timely filing a medical malpractice claim. Delaying this process can have significant
negative consequences on your ability to secure justice and compensation. Here's why you shouldn't delay in filing a medical malpractice claim.
A Crucial Step in Seeking Justice
When faced with legal challenges, finding the right lawyer is paramount. Your choice of legal representation can significantly impact the outcome of your case and
your overall experience throughout the legal process. Begin by identifying lawyers with expertise in your specific legal issue, whether it's personal injury, family
law, or business disputes.
Conduct thorough research, read client reviews, and seek recommendations from trusted sources to narrow down your options. Meet with potential attorneys for
consultations to assess their experience, communication style, and commitment to your case. Whether you are looking for a Scranton Medical Malpractice Lawyer or in
any other place, look for a lawyer who not only has the necessary skills and knowledge but also demonstrates empathy, transparency, and a genuine dedication to
advocating for your rights. By investing time and effort into finding the right lawyer, you set the foundation for a strong legal strategy and increase your chances
of a favorable resolution.
Thousands of cancer patients in England are set to gain fast-tracked access to personalised cancer vaccine trials through a new National Health Service(NHS)
initiative, the Cancer Vaccine Launch Pad.
This groundbreaking service aims to find new life-saving treatments by matching eligible patients with clinical trials across the country.
The first patient to receive a personalised vaccine for bowel cancer is Elliot Phebve, a 55-year-old lecturer, treated at University Hospitals Birmingham NHS
Foundation Trust.
Phebve, diagnosed through a routine health check, underwent surgery and chemotherapy before joining the trial.
Sponsored by German biotech company BioNTech SE, the colorectal cancer vaccine trial is one of several taking place across NHS trusts.
The Professional Records Standards Body (PRSB), which develops information standards for health and social care records, has appointed Professor Reecha
Sofat as the new Chair.
She will assume the role at the end of October 2024, succeeding Professor Maureen Baker CBE, who will step down after seven years as Chair of the PRSB.
A Clinical Pharmacologist, Professor Sofat has held many leadership roles across the NHS, academia and scientific societies.
Professor Sofat is Breckenridge Chair of Clinical Pharmacology at the University of Liverpool. She practices general internal medicine and is also an Associate
Director at the British Heart Foundation (BHF) Data Science Centre (DSC) which is led by Health Data Research UK (HDRUK).
With a passion for data science and extensive clinical and research insights, Professor Sofat is focused on embedding research into routine health and social care.
She said: "I am passionate about using the rich health data that is already collected across NHS and social care to better understand the causes and consequences
of disease and improve health outcomes.
The business landscape worldwide is undergoing a significant transformation, shifting from a sole focus on profitability to incorporating a broader spectrum
of considerations. Today, Environmental, Social, and Governance (ESG) criteria are integral to business operations, reflecting a commitment to sustainable and
ethical practices alongside financial growth.
ESG stands for three interconnected pillars: Environmental, focusing on reducing a company's ecological footprint; Social, addressing the impact on employees,
diversity, equity, inclusion, and the broader community; and Governance, which ensures responsible management practices, ethical behavior, and compliance with
regulations.
This holistic approach is becoming a critical foundation for long-term success in various industries, including healthcare. For the UK healthcare and pharmacy
sectors, integrating ESG not only aligns with global sustainability goals but also offers substantial benefits. This article delves into the specific implications
of ESG for UK pharmacies, highlighting how they can leverage these practices to foster both community well-being and business success.
The Galien Foundation recently announced the winners of the 2024 Prix Galien UK Awards, with the University of Oxford receiving accolades for its
groundbreaking contributions to public sector innovation through the PRINCIPLE and PANORAMIC Trials.
These trials, spearheaded by Oxford's team of experts, have set a new standard for scientific innovation aimed at improving global health outcomes.
Led by University of Oxford, the PRINCIPLE and PANORAMIC Trials epitomize a remarkable collaboration aimed at combating the COVID-19 pandemic.
Health and Social Care Secretary Wes Streeting reiterated his commitment to reducing NHS waiting lists during his visit to Frimley Health NHS Foundation
Trust's Heatherwood Hospital in Ascot on Friday.
Streeting toured the Berkshire hospital, which is helping tackle backlogs of planned operations with dedicated surgical services, thereby cutting local waiting lists.
The health secretary spoke to staff and patients at the hospital before meeting regional health representatives to discuss the issues facing services at a town
hall event.
His visit follows his recent call for an independent investigation into the NHS, pledging to be honest about the state of the health service and serious about
fixing it.
"The NHS is broken. Millions of patients are waiting too long for treatment, often in pain and discomfort," Streeting said.
Eighty-one per cent of the National Pharmacy Association cohort of trainee pharmacists passed the General Pharmaceutical Council (GPhC)'s common registration assessment which took place in June.
The NPA's team of learning and development pharmacists helped students prepare for the assessment with study days and mock exams.
Celebrating the success of trainee pharmacists, it said: "The 81 per cent NPA pass rate reflected the comprehensive blended learning experience delivered by the
NPA's team of learning and development pharmacists and that we were able to resume face-to-face study days for this cohort after the restrictions of lockdowns."
Last month, the GPhC and Pharmaceutical Society of Northern Ireland (PSNI) published result of the common registration assessment for pharmacists with an overall
pass rate of 80 per cent.
A total of 2,697 candidates sat the registration assessment in four countries on 29 June and 2,147 candidates passed the assessment.
The Royal Pharmaceutical Society (RPS) has published its new 'Core Advanced Pharmacist Curriculum' to enable professional development towards advanced pharmacist
practice.
This follows an intensive programme of work undertaken in collaboration with a wide range of UK stakeholders, the society said today (June 27) in a statement.
The Curriculum will equip pharmacists with advanced leadership, education, and research capabilities which are essential to support, lead and advance the profession
through transformative change so it continues to meet evolving patient and service requirements.
The RPS Core Advanced Curriculum provides the blueprint to develop such individuals by articulating a UK entry-level standard to advanced pharmacist practice,
relevant to all patient-focussed pharmacist roles and aligned to multi-professional definitions of advanced practice.
This curriculum completes the core RPS post-registration curricula, creating a seamless post-registration professional development continuum modelled around five
common domains- Person-centred care and collaboration; Professional practice; Leadership and management; Education; and Research.
Former superintendent pharmacist and National Pharmacy Association (NPA) director, Phil Galt, has been appointed the new UK managing director for pharmacy
software supplier Cegedim Rx.
The position was previously held by Adam Dennett, who resigned after a successful ten-year tenure to pursue a new career outside healthcare, the company said.
Cegedim Rx, the pharmacy entity of Cegedim Healthcare Solutions UK, announced the new appointment this month (April 5).
Tristan de Foucher, head of European operations for Cegedim Group, said: "Adam has been a force of nature in this business for the past 10 years. Under his
leadership, the team has continuously and successfully invested in and driven product innovation to stay ahead of the ever-changing demands placed upon community
pharmacy."
Galt has over 20 years of experience as a qualified pharmacist and a successful business leader. He has worked extensively in community pharmacy, focusing on
both care delivery and technology implementation.
At their recent online briefing, DAUK's GP committee outlined a comprehensive 10-point plan designed to relieve pressure on GPs, improve access, reduce
mortality rates, lower hospital admissions, and enhance patient satisfaction.
DAUK's manifesto advocates reallocating resources, including the Additional Roles Reimbursement Scheme (ARRS), currently directed towards Pharmacy First and
acute care hub pilots, amounting to £2 billion.
This strategic reallocation aims to enhance primary care capacity and reduce reliance on acute services.
Dr Lizzie Toberty, DAUK's GP lead, emphasised the critical need for patients to have timely access to GPs who understand their needs, stating, "We need patients
to be able to see a GP who knows them and understands their needs in a timely way wherever possible."
She highlighted DAUK's vision to restore general practice as the cornerstone of the NHS through practical, achievable solutions.